bioMérieux Stock Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.77B 10.24B 8.2B 7.51B 14.09B 979B 14.28B 96.93B 37.8B 492B 38.43B 37.6B 1,627B | P/E 2026 * |
18.2x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.36B 9.76B 7.82B 7.16B 13.44B 934B 13.62B 92.42B 36.04B 469B 36.65B 35.85B 1,552B | EV / Sales 2026 * |
2.03x | EV / Sales 2027 * | 1.85x |
| Free-Float |
33.22% | Yield 2026 * |
1.4% | Yield 2027 * | 1.55% |
Last Transcript: bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 01/07/2023 |
| Director of Finance/CFO | 50 | 01/03/2018 | |
| Chief Tech/Sci/R&D Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 15/12/2017 | |
| Director/Board Member | 66 | 01/01/2005 | |
| Director/Board Member | 61 | 30/05/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 10.24B | |
| +1.67% | +8.57% | +178.54% | +352.16% | 22.91B | |
| -0.13% | +1.92% | -41.52% | -19.91% | 10.24B | |
| +1.96% | +16.10% | +397.10% | +40.59% | 8.48B | |
| +6.88% | +20.50% | -31.09% | - | 7.42B | |
| -0.27% | -0.97% | +68.98% | +48.50% | 6.53B | |
| -4.95% | +1.23% | -12.97% | -3.17% | 6.06B | |
| +1.49% | -3.43% | +69.95% | +106.00% | 4.41B | |
| +0.56% | +0.97% | -12.93% | -15.99% | 4.34B | |
| -0.86% | +2.76% | -17.52% | -26.19% | 2.94B | |
| Average | +0.61% | +5.18% | +66.50% | +60.25% | 8.15B | |
| Weighted average by Cap. | +0.92% | +6.74% | +100.58% | +133.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.81B 3.86B 3.53B 6.63B 461B 6.72B 45.59B 17.78B 231B 18.08B 17.69B 765B | 4.34B 5.06B 4.06B 3.72B 6.97B 484B 7.06B 47.95B 18.7B 243B 19.01B 18.6B 805B |
| Net income | 482M 563M 451M 413M 775M 53.88B 786M 5.33B 2.08B 27.07B 2.11B 2.07B 89.53B | 525M 613M 492M 450M 844M 58.67B 856M 5.81B 2.26B 29.47B 2.3B 2.25B 97.49B |
| Net Debt | -408M -476M -381M -349M -655M -45.54B -664M -4.51B -1.76B -22.87B -1.79B -1.75B -75.66B | -731M -854M -684M -626M -1.18B -81.68B -1.19B -8.08B -3.15B -41.03B -3.21B -3.14B -136B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
